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Abstract  
Aim: The aim of the study was to investigate the restoration of 
metabolic imbalance related with deficiency of insulin by the exogenous 
androgen supplementation in the experimental model of alloxan-induced 
diabetes in Wistar male rats. Methods: The experimental diabetes was 
induced by a single intraperitoneal administration of alloxan. The 
concentrations of glucose, immunereactive insulin, corticosterone, 
testosterone and estradiol were examined in blood, the intensity of DNA and 
RNA synthesis and androgen receptor expression were studied in the liver 
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tissue – at 15th, 30th and 45th days of alloxan-induced diabetes. The synthetic 
androgen methyltrienolone was administered to rats with 30-days diabetes 
during 15 days. All data were compared to control group received solvent. 
Results: The induction of diabetes increased the concentrations of glucose, 
corticosterone and estradiol while decreases insulin and testosterone 
concentration in blood as well as DNA/RNA synthesis and androgen 
receptors expression in hepatocytes. The administration of exogenous 
androgen significantly restored the metabolic imbalance and the expression 
of androgen receptors and increased DNA/RNA synthesis in liver cells 
maintained close to control level. Conclusion: The administration of 
methyltrienolone reduced the effect of “diabetic stress” and restored the 
hormonal dysfunction induced by alloxan. 
 
Keywords: Alloxan-induced diabetes, testosterone, liver androgen receptors, 
hormonal disbalance 
 
Introduction 
 According to World Health Organization data, the incidence of 
diabetes mellitus (DM) has been obviously increasing over the world during 
the last decades. Both types of DM (type 1 and type 2) are characterized by 
chronic hyperglycemia and disorders in metabolism of carbohydrates, 
proteins and fats (American Diabetes Association, 2009), with multi-organ 
involvement in the pathogenesis (Hotamisligil, 2006).  
 The gender difference in the population affected by DM has been 
demonstrated by numerous epidemiological studies (Fitzgerald, et al., 1995; 
Grant, et al, 2009; Siddiqui, et al., 2013). It is considered that males have 
higher prevalence and diabetes type 2 risk (Aregbesola ET AL., 2016; 
Kautzky-Willer, et al., 2016). In addition, the risk of men with type 1diabetes 
by cardiovascular disease mortality is approximately 10 times that of men 
without diabetes (Orchard, et al., 1990). Moreover the diabetes is considered 
as one of the strongest independent predictors of left ventricular hypertrophy 
(Greaves, et al., 1994).  
 Sex hormones have a great impact on energy metabolism, body 
composition, vascular function, and inflammatory responses (Kautzky-
Willer, et al., 2016). The credible decrease of plasma testosterone 
concentration has been shown in males affected by DM type 1 as well as 
type 2. It was shown that the low concentrations of endogenous testosterone 
correlates with increased risk for left ventricular hypertrophy and heart 
failure (Kannel, et al., 1969; Kannel, et al., 1972). It is also reported that the 
reduction of blood testosterone concentration leads to the changes of 
metabolic processes in liver, hyperglycemia and insulin resistance in men 
with both types of DM (Grossmann, 2008; Holt, 2014). The low level of 
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blood testosterone is related to worst outcome in advanced liver diseases 
(Sinclair, 2016). The influence of sex hormones on the insulin secretion by 
β-cells in pancreas and metabolic processes in liver has been proved 
(Morimoto, 2001; Shen & Shi, 2015).  
 Considering, that hepatocytes and β-cells have the receptors for both 
male and female sex hormones, which in turn, have the ability of changing 
their quantitative expression (“down-regulation” and “up-regulation”) 
accordingly to their blood concentration, it could be expected that sex 
hormones supplementation may have functional pancreatic and hepatic 
repercussions in DM.  
 At the same time it's shown that male’s liver, compared to female’s, 
is more dependent on the genetically determined androgen levels in blood 
(Smirnov, 2009). 
 The aim of the present study was to investigate the possibility of 
restoration of metabolic imbalance by the exogenous androgen 
supplementation in the experimental model of alloxan-induced diabetes 
(AD).  
  
Material And Methods 
 The experimental model of diabetes was induced in male Wistar white 
rats (n=80) in age 2-2,5 months, weighting 180-200 g by a single 
intraperitoneal administration of alloxan obtained from Chemos GmbH & 
Co.KG (Germany). The animals received alloxan 200 mg/kg body weight in 
accordance to the pattern of experimental group. The animals were divided 
into 5 groups: Group I (Control) (n = 20) received solvent; Group II (n = 20) 
studied on 15th day of AD; Group III (n = 20) studied on 30th day of AD; 
Group IV (n = 20) studied on 45th day of AD; Group V (n=20) received daily 
0.5 mg of synthetic androgen - radioinert methyltrienolone - beginning from 
the 31st day of AD. One hour before sacrifice, all animals underwent to the 
intraperitoneal injection of 3,7x104 Bq radioactive androgen -  
methyltrienolone [17a-METHYL-3H] (R-1881) obtained from Perkin Elmer, 
Inc., for quantitative assessment of androgen receptors (AR) in liver.  
 Subsequently, the animals were given ether anesthesia and the blood 
samples were obtained from inferior vena cava to further measuring the 
levels of glucose, immunoreactive insulin (IRI), corticosterone, estradiol (E2) 
and testosterone (T). The study corresponded to the principles of the Guide 
for the Care and Use of Laboratory Animals (NRC 2011) and approved by 
the Commission on Bioethics at Al. Natishvili Institute of Morphology, Iv. 
Javakhishvili Tbilisi State University.  
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Measurement of hormones 
 The levels of hormones were measured by commercial kits. IRI was 
determined using the assay from SEA-IRE-SORIN (France); corticosterone 
was assessed using the assay from RSL., Inc. (California, US), T - by SORIN 
BIOMEDICA (Italy) and E2 - by ORIS Industries S.A. International GIS 
(France).  
 
Measurement of hepatic DNA/RNA content 
  The quantity of DNA in liver was studied by radioactive H3-
thymidine (I.U. 8.14 x 1011 Bq/ml) in the dose of 3.7х 105 Bq/ml, while the 
RNA was measured by radioactive H3-uridine (I.U. 8.8 х 1011 Bq/ml) in the 
dose of 3.7х 106 Bq/ml. For this purpose, the fragments of liver tissue were 
weighed and placed into 5 ml 199 solution vials, to which the above specific 
radioactive components were added.  
 The vials were placed in thermostat at +380С for 90 minutes. Later, 
the fragments were rinsed in cold (+4ºС) nourishing buffer with subsequent 
homogenization and placement in scintillating fluid container vials 
(according to previously published recommendations (Didebulidze, et al., 
2015.  The frequency (quantity) of radioactive impulses (imp/gr/min) was 
calculated by the “β-2” device (produced by the Enterprise of Academy of 
Medical Sciences, Russia).   
 
Statistical analysis    
 Median values are provided with respective interquartile ranges. 
Comparisons were tested using Mann-Whitney U test. P values less than 
0.05 were considered statistically significant. Statistical analysis was 
conducted using SAS 9.2 software. 
 We preferred median over mean because of concerns regarding the 
normality of distribution and small sample size of our study. Therefore we 
thought that median values are more appropriate to describe our data and 
make comparison between groups, which consisted of 20 subjects each.   
 
Results and Discussion 
 AD was accompanied by the increased plasma concentration of 
glucose, corticosterone and E2. This increase appeared to be statistically 
significant compared with data of control group and groups with lesser terms 
of AD as well. The plasma concentration of IRI and T has significantly 
decreased at 15th and 30th days of the experiment but on the 45th day their 
further changes compared with previous terms were not statistically 
significant (Table 1, Diagram 1).  
 This could be related to the reduction of damaging effect of alloxan at 
45th day when pancreatic β-cells entered into regeneration phase. The 
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reduction of intensity of IRI decline is accompanied by the reduction of 
intensity of T decline as well as it was described by Kandeel, et al. (2007). It 
is established that hypoinsulinemia and decreased glucose utilization inhibit 
protein, DNA and RNA synthesis in hepatocytes. In our study, hepatic DNA 
synthesis was decreased by 44% and RNA synthesis by 29% at 15th day of 
AD. In case of hypoinsulinemia and hyperglycemia, the glucose, which 
abundantly penetrated into hepatocytes (insulin is not required for the 
entrance of glucose in the hepatocytes, but only for its utilization by the cells 
- Kelly & Jones, 2013) promotes a significant increase in the production of 
hydroxyl radicals, which increase the amount of Bcl-2-associated X protein 
(BAX-protein). Besides, BAX protein stimulates the release of cytochrome 
C from mitochondria, caspase-3 activation and induction of apoptosis 
(Frances, et al., 2010). 
 After injection of radio-inert methyltrienolone, the glucose level 
significantly decreased being not statistically different in comparison with 
the data obtained at 15th day of experiment. This can be explained by the 
fact, that testosterone promotes the synthesis of i-RNA of IRI receptors in 
hepatocytes, which leads to increased sensitivity of hepatocytes toward IRI. 
In this conditions the minimal rise of IRI is enough to stimulate the glucose 
utilization in liver cells (Kapoor, et al., 2006; Sato, et al., 2008). IRI exerts 
anti-apoptotic properties based on the stimulation of XIAP, which inhibits 
caspases and suppresses the apoptosis (Frances, et al., 2010). 
 Our study, supports that injection of exogenous androgen 
supplementation significantly increases DNA (24%) and RNA (8%) 
synthesis in liver (Diagram 2).  
 T shifts insulin signaling toward cellular protein anabolism (Shahidi, 
2001). T increases Glut4 expression and downstream signaling such as Akt 
and PKC-zeta/lambda phosphorylations and the main glycolytic 
phosphofructokinase and hexokinase enzymes (Sato, et al., 2008). Injection 
of methyltrienolone, had no effect on the concentration of IRI: the latter was 
not different neither from the data obtained at 30th nor 45th days of AD 
model. 
 Due to reduction of rat β-cells-derived insulin by alloxan imply, the 
synthesis of T is not stimulated adequately. Reduced T concentration can no 
longer afford inhibition of lipoprotein lipase enzyme. This enzyme, located 
at the endothelial membranes of blood capillaries into adipose tissue, 
releases the triglycerides from fat rich chylomicrons and very low density 
lipoproteins; these triglycerides penetrate and deposit into adipocytes. Under 
these conditions the enzyme aromatase, located in adipocytes, is activated 
and converts already diminished T to estrogen. This observation is confirmed 
by our data in which the marked increase in E2 concentration paralleled the 
decrease in the T concentration (Hayes, et al., 2000, 2001). However, the E2 
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concentration which was increased at all stages of the experiment still 
declined after methyltrienolone injection and was not statistically different 
from indices of 15th day of AD (Table 1, Diagram 1).  
 The presented data confirms the results of Shahidi (2001), Haffner, et 
al. (1988) and Pitteloud, et al. (2005) that the variability in the steroid 
hormone concentration is dependent on insulin and glucose levels and vice 
versa.  
 At the 15th day of AD it was observed an increase of liver AR 
expression (Diagram 2). This can be explained by active consumption of 
testosterone during alloxan-dependent stress that increased the number of 
free AR enabled to interact with radioactive androgen H3-methyltrionolone 
(R-1881). At subsequent stages the increased testosterone deficiency induced 
by experimental diabetes was associated with drastic down-regulation of AR 
expression and signaling (due to their “masking”)  (Tepperman, 1968; 
Moudgil, 1988,1990). 
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Table 1.  Blood concentration of glucose, IRI, Т, Е2, corticosterone (Cor); activity of nucleic 
acids (DNA and RNA) synthesis; expression of AR. 
 
Number of (*) indicates the group which data is compared to the data of given group    
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1509.53  
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European Scientific Journal May 2017 edition Vol.13, No.15 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
29 
Diagram 1. Concentrations (in percents) of glucose, IRI, corticosterone, E2 and T in blood 
of male rats.  
 
 
Diagram 2. Levels of DNA and RNA synthesis and AR expression in the liver tissue of 
male rats.  
 
 
 However, the administration of synthetic androgen during 15 days 
followed by increased T level in blood plasma lead to up-regulation and 
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activation (“de-masking”) of AR. Data showed that receptor binds to 
radioactive H3-methyltrienolone and cause further increase on the AR 
expression in liver tissue. 
 Despite the expression of liver AR after treatment with H3-
methyltrinolone does not reach the control level, an increase in their number 
significantly supports the restoration of liver function, including adaptive-
compensatory activities (Smirnov, 2009). 
 The increased glucose blood concentration during AD may be related 
to reduced glucose-related metabolism caused by enhanced corticosterone 
signaling. Under such circumstances, the increased level of steroid hormones 
stimulates gluconeogenesis from protein and amino acids metabolism (Imai, 
et al., 1993; Andrews & Walker, 1999; Kinote, et al., 2012). The 
supplementation of H3-methyltrienolone reduced IRI resistance, 
hyperglycemia, corticosterone and E2 drastically altered during experimental 
diabetes in male rats.   
 
Conclusion 
 The present study showed that AD alters IRI resistance and glucose-
related metabolism as well as the levels of both gonadal and adrenal steroids 
in blood plasma confirming the presence of “metabolic stress”. The 
administration of exogenous androgen reduced the effect of “stress” and 
recovers the hormonal dysfunction induced by alloxan.  
 Restoration/functional activation of liver AR by methyltrienolone 
accompanied by increased DNA and RNA synthesis in hepatocytes plays the 
significant role in restoration of metabolic imbalance caused by AD. 
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